Even ‘low-risk’ patients need drugs after STEMI, say cardiologists
A growing cohort of patients without traditional CV risk factors are at high risk of death post-MI, research suggests
A neglected subset of patients with ST-elevation MI but no traditional cardiovascular risk factors are nearly 50% more likely to die prematurely than STEMI patients deemed at high risk of a second event, Australian research reveals.
The difference in all-cause mortality was most pronounced among female STEMI patients with no cardiovascular risk factors, who were least likely to receive medication for secondary prevention, the large observational study showed.
